Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Veterinary Active Pharmaceutical Ingredients Manufacturing Market Grown from 2024 to 2025?
The market for manufacturing active pharmaceutical ingredients for veterinary use has been on a significant upward trend in the past few years. The market size is projected to rise from $7.46 billion in 2024 to $8.05 billion in 2025, registering a compound annual growth rate (CAGR) of 7.9%. This growth trajectory seen in the historical period is largely influenced by factors such as an increase in pet ownership, the enforcement of strict regulatory standards, heightened emphasis on animal nutrition, increased investment in research and development, and general global economic growth.
What Growth Rate Is Anticipated for the Veterinary Active Pharmaceutical Ingredients Manufacturing Market in the Coming Years?
The market for manufacturing veterinary active pharmaceutical ingredients is projected to experience robust growth in the coming years, escalating to a worth of $11.19 billion in 2029 with a compound annual growth rate (CAGR) of 8.6%. This projected growth during the forecast period can be credited to factors such as the development of tailored veterinary medicine, global expansion and market proliferation, a heightened focus on regulatory adherence, the growing significance of animal well-being, progress in drug delivery systems, and an increased demand for nutraceuticals. Foreseen trends in this growth span include advancements in manufacturing methodologies, a rising trend in the outsourcing of API manufacturing, a transformation towards biotech-based APIs, the incorporation of digitalization and automation in production, and the globalization of the veterinary API market.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7942&type=smp
Who Are the Leading Companies in the Veterinary Active Pharmaceutical Ingredients Manufacturing Market?
Major companies operating in the veterinary active pharmaceutical ingredients manufacturing market are Alivira Animal Health Limited, Excel Industries Limited, Ofichem Group B.V., Jiangsu Lingyun Pharmaceutical Co. Ltd., SUANFARMA S.A., NGL Fine-Chem Limited, FIS – Fabbrica Italiana Sintetici S.p.A., Lupin Limited, Aurobindo Pharma Limited, Saneca Pharmaceuticals AS, Neuland Laboratories Limited, Divi’s Laboratories Limited, Zoetis Inc., Grupo Indukern S.L., Sequent Scientific Limited, Chempro Pharma Private Limited, AMGIS Lifescience Ltd., Huvepharma AD, Vetpharma Animal Health S.L., Qilu Pharma Spain S.A., INDUKERN Chemie AG, Chemopharma S.A., Norbrook Laboratories Limited, Ceva Santé Animale S.A., Vetoquinol S.A., Virbac S.A.
What Are the Key Drivers of the Veterinary Active Pharmaceutical Ingredients Manufacturing Market?
The rise in pet adoption is anticipated to boost the expansion of the market for manufacturing veterinary active pharmaceutical ingredients. Pet keepers are those who possess or adopt a pet animal and offer necessary healthcare arrangements for their pets, thereby escalating the need for veterinary medicines. As an example, Animal Medicines Australia, a non-profit organization based in Australia, reported a significant increase in pet ownership in the year 2022. They documented an increase from 39% in 2021 to 28,730.8 pet owners in 2022, marking a 24% growth. This indicates a significant surge in the adoption of pets and investments in pet care, underlining the mounting popularity of pets in Australian homes. Consequently, the rising number of individuals owning pets fuels the market for the production of veterinary active pharmaceutical ingredients.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=7942&type=smp
What Are the Key Market Segments in the Veterinary Active Pharmaceutical Ingredients Manufacturing Industry?
The veterinary active pharmaceutical ingredients manufacturing market covered in this report is segmented –
1) By Product: Antiparasitic, Anti-Infectives, Vaccines, NSAIDs
2) By Service Type: In House, Contract Outsourcing
3) By Synthesis Type: Chemical Based API, Biological API, Highly Potent API
Subsegments:
1) By Antiparasitic: Endectocides, Anthelmintics, Antiprotozoals
2) By Anti-Infectives: Antibiotics, Antifungals, Antivirals
3) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines
4) By NSAIDs (Non-Steroidal Anti-Inflammatory Drugs): Non-Selective NSAIDs, COX-2 Inhibitors
What Are the Latest Trends in the Veterinary Active Pharmaceutical Ingredients Manufacturing Market?
One significant trend that is emerging in the veterinary active pharmaceutical ingredient manufacturing market is product innovation. To maintain their dominance in the market, the leading companies are focusing on developing innovative products. For example, in January 2022, Zoetis Inc., a US-based company that manufactures drugs for livestock and pets, received approval from the US FDA for Solensia (frunevetmab injection), designed to manage osteoarthritis (OA) pain in cats. Solensia, which is the only injectable monoclonal antibody therapy for feline OA pain approved in the United States, functions by targeting and neutralizing nerve growth factor (NGF), a primary contributor to osteoarthritis pain.
Access The Full Report Here:
What Are the Key Regional Markets in the Veterinary Active Pharmaceutical Ingredients Manufacturing Industry?
North America was the largest region in the veterinary active pharmaceutical ingredients manufacturing market in 2024. The regions covered in the veterinary active pharmaceutical ingredients manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7942
This Report Delivers Insight On:
1. How big is the veterinary active pharmaceutical ingredients manufacturing market, and how is it changing globally?
2. Who are the major companies in the veterinary active pharmaceutical ingredients manufacturing market, and how are they performing?
3. What are the key opportunities and risks in the veterinary active pharmaceutical ingredients manufacturing market right now?
4. Which products or customer segments are growing the most in the veterinary active pharmaceutical ingredients manufacturing market?
5. What factors are helping or slowing down the growth of the veterinary active pharmaceutical ingredients manufacturing market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
